European Union
In force Implementing regulation 29 units
Commission Implementing Regulation (EU) 2023/1436 of 10 July 2023 concerning the non-renewal of the approval of the active substance dimoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408 (Text with EEA relevance)
Commission Implementing Regulation (EU) 2023/1436 of 10 July 2023 concerning the non-renewal of the approval of the active substance dimoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408 (Text with EEA relevance)eu-implementing-regulation-2023-07-10-1436Jul 10, 2023
- Preamble 1
- recital 1 recital 1
- recital 2 recital 2
- recital 3 recital 3
- recital 4 recital 4
- recital 5 recital 5
- recital 6 recital 6
- recital 7 recital 7
- recital 8 recital 8
- recital 9 recital 9
- recital 10 recital 10
- recital 11 recital 11
- recital 12 recital 12
- recital 13 recital 13
- recital 14 recital 14
- recital 15 recital 15
- recital 16 recital 16
- recital 17 recital 17
- recital 18 recital 18
- recital 19 recital 19
- recital 20 recital 20
- recital 21 recital 21
- recital 22 recital 22
- Article 1 Non-renewal of the approval of the active substance
- Article 2 Amendment to Implementing Regulation (EU) No 540/2011
- Article 3 Amendment to Implementing Regulation (EU) 2015/408
- Article 4 Transitional measures
- Article 5 Grace period
- Article 6 Entry into force